Cannabismarketcap

BioHarvest Sciences Stock Forecast & Price Prediction 2026-2027

Algorithmic price targets and analysis for BHST based on fundamentals, valuation multiples, and historical data.

$1.67-4.58%
Bullish

Price Target Summary

Bear Case
$1.33
-20.0% from current
Base Case
$5.21
+213.2% from current
Bull Case
$9.39
+463.7% from current

Technical Outlook

52-Week Range Analysis

$1.37$12.65
Current: $1.67
Support Level
$2.50
Resistance Level
$11.52
From 52W High
-86.8%
From 52W Low
+21.4%

Fundamental Analysis

Revenue Growth Projection

Year 1 Projected
$47.3M
Year 2 Projected
$61.3M
Year 3 Projected
$74.9M

Based on +37.0% YoY growth, tapered 20% per year in outer projections.

Valuation vs Peers

Current P/S
3.75x
Sector Median P/S
2.5x
Assessment
Premium to sector

Cash Position

Cash on Hand
$23.0M
Total Debt
$149.0K
Cash Runway
38 mo

Key Metrics

Current Price$1.67
Market Cap$37.7M
P/S Ratio3.75x
Revenue (TTM)$34.5M
Revenue Growth (YoY)+37.0%
Gross Margin59.3%
Cash on Hand$23.0M
Total Debt$149.0K
52W High$12.65
52W Low$1.37

Signal Breakdown

Overall Signal: Bullish
  • Strong revenue growth above 10% YoY
  • Healthy gross margins above 40%
  • Cash exceeds total debt
  • Trading more than 50% below 52-week high
  • Elevated P/S ratio relative to sector

Risk Factors

  • Cannabis remains federally illegal in the United States, creating regulatory uncertainty.
  • The cannabis sector is highly competitive with ongoing price compression in many markets.

Analyst Summary

BioHarvest Sciences (BHST) is a cannabis biotech company with rapidly growing revenue and a market capitalization of $37.7M. Based on trailing revenue of $34.5M and a P/S ratio of 3.75x, the stock trades at a premium relative to the sector median of 2.5x. Our algorithmic base-case price target of $5.21 implies upside of 213.2% from current levels. The overall signal is bullish, supported by positive fundamental indicators. Investors should weigh the 2 identified risk factors before making any investment decision.

Frequently Asked Questions

What is the price target for BHST?+
Our algorithmic base-case price target for BioHarvest Sciences (BHST) is $5.21, with a bear case of $1.33 and a bull case of $9.39. These targets are derived from sector-average and premium P/S multiples applied to projected revenue.
Is BHST a buy right now?+
Based on our algorithmic analysis, BHST currently carries a bullish signal. Strong revenue growth above 10% YoY. Healthy gross margins above 40%. This is not a buy or sell recommendation — always do your own due diligence.
What is the revenue forecast for BioHarvest Sciences?+
Based on the current year-over-year growth rate of +37.0%, we project BHST revenue at $47.3M in Year 1, $61.3M in Year 2, and $74.9M in Year 3. Growth rates are tapered in outer years.
What are the risks of investing in BHST?+
Cannabis remains federally illegal in the United States, creating regulatory uncertainty. The cannabis sector is highly competitive with ongoing price compression in many markets.
How does BHST valuation compare to the cannabis sector?+
BHST has a trailing P/S ratio of 3.75x compared to the cannabis sector median of 2.5x. The stock premium to sector.

Important Disclaimer

This is not financial advice. Forecasts are algorithmic projections based on historical data and should not be used as the sole basis for investment decisions. Past performance does not guarantee future results. Cannabis stocks carry significant risk including regulatory, market, and operational risks. Always consult with a qualified financial advisor before making investment decisions. Cannabismarketcap does not recommend buying, selling, or holding any security.

← Back to BHST OverviewAll Cannabis Stocks